Finance

Lists
Why is 600594 down 2,61%?
Dive Deeper
600594:SHA
GuiZhou YiBai Pharmaceutical Co., Ltd.
3,36 CN¥
-2,61%
(-0,090) 1D
19 հոկ, 09:52:56 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600594...
Open
3,41 CN¥
High
3,47 CN¥
Low
3,35 CN¥
Mkt. cap
2,71 մլրդ
Avg. vol.
30,69 մլն
Volume
4,08 մլն
52-wk high
5,27 CN¥
52-wk low
2,85 CN¥
EPS
-0,49 CN¥
Shares outstanding
791,93 մլն
No. of employees
5 հզր
Open
3,41 CN¥
High
3,47 CN¥
Low
3,35 CN¥
Mkt. cap
2,71 մլրդ
Avg. vol.
30,69 մլն
Volume
4,08 մլն
52-wk high
5,27 CN¥
52-wk low
2,85 CN¥
EPS
-0,49 CN¥
Shares outstanding
791,93 մլն
No. of employees
5 հզր
News stories
From web sources and news partners
About GuiZhou YiBai Pharmaceutical Co., Ltd.
CEO-
Employees4,83 հզր
Founded12 հնս, 1995 թ.
Headquarters-
Sector-
Websitegzcci.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
453,58 մլն
416,22 մլն
358,84 մլն
330,55 մլն
Cost of goods sold
165,60 մլն
205,61 մլն
150,99 մլն
171,44 մլն
Cost of revenue
165,60 մլն
205,61 մլն
150,99 մլն
171,44 մլն
Research and development expenses
25,31 մլն
21,85 մլն
13,47 մլն
18,05 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
276,16 մլն
283,81 մլն
196,25 մլն
197,70 մլն
Operating expense
292,28 մլն
328,94 մլն
213,94 մլն
224,89 մլն
Total operating expenses
457,88 մլն
534,55 մլն
364,93 մլն
396,33 մլն
Operating income
-4,30 մլն
-118,33 մլն
-6,09 մլն
-65,78 մլն
Other non operating income
-1,51 մլն
-122,19 հզր
-228,77 հզր
-301,40 հզր
EBT including unusual items
-69,17 մլն
-218,73 մլն
-20,88 մլն
-52,20 մլն
EBT excluding unusual items
-11,96 մլն
-123,43 մլն
-11,52 մլն
-71,19 մլն
Income tax expense
-898,39 հզր
25,98 մլն
8,09 մլն
-2,70 մլն
Effective tax rate
1,30%
-11,88%
-38,74%
5,17%
Other operating expenses
-9,81 մլն
23,29 մլն
4,27 մլն
9,51 մլն
Net income
-66,66 մլն
-243,00 մլն
-29,52 մլն
-50,81 մլն
Net profit margin
-14,70%
-58,38%
-8,23%
-15,37%
Earnings per share
-
-
-
-
Interest and investment income
1,13 մլն
979,10 հզր
485,26 հզր
583,10 հզր
Interest expense
-7,28 մլն
-5,96 մլն
-5,69 մլն
-5,69 մլն
Net interest expenses
-6,15 մլն
-4,98 մլն
-5,21 մլն
-5,11 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
41,68 մլն
-77,35 մլն
34,89 մլն
-28,17 մլն
Gain or loss from assets sale
17,43 հզր
27,21 մլն
-
-1,83 մլն
AI content may include mistakes. Learn more
Google Apps